A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis

Dezheng Dong, Christopher J. Stapleton, Biquan Luo, +12

Cancer Research

ApoptosisBiological MicroenvironmentsCell DeathCell ProliferationCancer Biology +17

Monoamine oxidase A (MAO A) inhibitors decrease glioma progression

Swati Kushal, Weijun Wang, Vijaya Vaikari, +8

Oncotarget

Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas

Hee‐Yeon Cho, Weijun Wang, Niyati Jhaveri, +11

Molecular Cancer Therapeutics

Neuro-oncologyOncogenic AgentMedicineTumor GrowthCell Death +12

NEO212, Temozolomide Conjugated to Perillyl Alcohol, Is a Novel Drug for Effective Treatment of a Broad Range of Temozolomide-Resistant Gliomas

Hee‐Yeon Cho, Weijun Wang, Niyati Jhaveri, +6

Molecular Cancer Therapeutics

Chemoprevention StrategyPathologyTemozolomide-resistant GliomasPharmacotherapyHigh-grade Gliomas +15

Noscapine inhibits tumor growth in TMZ-resistant gliomas

Niyati Jhaveri, Heeyeon Cho, Shering Torres, +6

Cancer Letters

Neuro-oncologyMedicineTumor GrowthAnti-cancer AgentCancer Treatment +5

Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy

Habib Sadeghirad, Ning Liu, James Monkman, +13

Frontiers in Immunology

Neoadjuvant TherapyImmunologyBiological MicroenvironmentsPathologyImmunotherapy +14

Sequential Administration of Carbon Nanotubes and Near-Infrared Radiation for the Treatment of Gliomas

Tiago Santos, Xin Fang, Meng-Tse Chen, +8

Frontiers in Oncology

NEO212, a conjugate of temozolomide and perillyl alcohol, blocks the endothelial-to-mesenchymal transition in tumor-associated brain endothelial cells in glioblastoma

Nagore I. Marín‐Ramos, Niyati Jhaveri, Thu Zan Thein, +3

Cancer Letters

Neuro-oncologyEndothelial-to-mesenchymal TransitionMedicineCancer BiologyPerillyl Alcohol +6

A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo

Thomas C. Chen, Hee‐Yeon Cho, Weijun Wang, +5

Cancer Letters

Tumor BiologyOncologyEnhanced ActivityMedicineMelanoma +7

A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells

Niyati Jhaveri, Fabienne Agasse, Don Armstrong, +11

Cancer Letters

GliomaMedicineStem CellsNovel Drug ConjugateMesenchymal Subtypes +9